[
  {
    "ts": "2025-12-02T13:00:00+00:00",
    "headline": "Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors",
    "summary": "MILLBRAE, Calif., December 02, 2025--Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge research to accelerate drug discovery, today announced the election of David W. Meline as an independent director effective November 23, 2025. Mr. Meline is the former Chief Financial Officer at Moderna Inc.",
    "url": "https://finance.yahoo.com/news/eikon-therapeutics-announces-election-david-130000866.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "22c9d48c-922e-303b-b487-670e54db91fc",
      "content": {
        "id": "22c9d48c-922e-303b-b487-670e54db91fc",
        "contentType": "STORY",
        "title": "Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors",
        "description": "",
        "summary": "MILLBRAE, Calif., December 02, 2025--Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge research to accelerate drug discovery, today announced the election of David W. Meline as an independent director effective November 23, 2025. Mr. Meline is the former Chief Financial Officer at Moderna Inc.",
        "pubDate": "2025-12-02T13:00:00Z",
        "displayTime": "2025-12-02T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/5c3f0ac3d5fe382851c4eab52f4f173f",
          "originalWidth": 480,
          "originalHeight": 311,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d54fLWcXZYifeaH93LLQWQ--~B/aD0zMTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5c3f0ac3d5fe382851c4eab52f4f173f.cf.webp",
              "width": 480,
              "height": 311,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lcWsieYrW5aJhl0MXJE10A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5c3f0ac3d5fe382851c4eab52f4f173f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eikon-therapeutics-announces-election-david-130000866.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eikon-therapeutics-announces-election-david-130000866.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "MMM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]